Curriculum Vitae
Meera Mahalingam, MD, PhD, FRCPath
2/12/2016
ACADEMIC TRAINING
1985
M.B, B.S
Darbhanga Medical College, Mithila University, Darbhanga, India
1988
M.S.
College of Medicine, University of Florida, Gainesville, FL, USA
1995
Ph.D.
University of London, London, UK
POSTDOCTORAL TRAINING
1998-00
Fellowship
Dermatopathology, Dermatopathology Section, Department of Dermatology
Boston University School of Medicine, Boston, MA, USA
1995-98
1989-95
Residency
Anatomic & Clinical Pathology, Department of Pathology, Boston Medical Center
(USA)
Boston, MA, USA
Residency
Anatomic & Clinical Pathology, Arrowe Park/Royal Liverpool Hospital, Ashford Hospital,
(UK)
Middlesex, King’s College Hospital, London, UK
ACADEMIC APPOINTMENTS
2009-
Professor of Dermatology and Pathology and Laboratory Medicine
Boston University School of Medicine, Boston, MA, USA
2007-2009
Associate Professor of Dermatology and Pathology,
Associate Program Director, Dermatopathology fellowship Program
Boston University School of Medicine, Boston, MA, USA
2005–2007
Associate Professor of Pathology and Medicine (Dermatology)
Dermatopathology Fellowship Program Director
UMASS Medical School, Worcester, MA, USA
2000-2002
Adjunct Assistant Professor of Pathology,
Boston University School of Medicine, Boston, MA, USA
1994-1995
Lecturer, Immunology, KIng’s College School of Medicine
London, UK
HOSPITAL & OTHER APPOINTMENTS
2008-
Faculty, Genome Science Institute, BUSM, Boston, MA, USA
2005-2007
Director Dermatopathology, UMASS Memorial Health Care, Worcester, MA, USA
2000-2005
Dermatopathologist, Quest Diagnostics Incorporated, Cambridge, MA, USA
Consultant Dermatopathologist, Quest Diagnostics Incorporated, CT, PA, USA
1998–2000
Dermatopathology Fellow, Dermatopathology Section,
Department of Dermatology, Boston Medical Center, MA, USA
1995–1998
Anatomic & Clinical Pathology Resident, Department of Pathology,
Boston Medical Center, Boston, MA, USA
1994-1995
Sr. Registrar, Department of Clinical Immunology, King’s College Hospital, London, UK
1990-1994
Registrar, Department of Clinical Immunology, King's College Hospital
London, UK
1989-1990
Pathology Resident, Department of Pathology, Ashford Hospital, Middlesex,UK
Arrowe Park & Royal Liverpool Hospital, Liverpool, UK
1984-1985
Pediatrics and Surgery Resident, Departments of Pediatrics and General Surgery
Safdarjang Hospital, New Delhi, India
1983-1984
Intern, Safdarjang Hospital, New Delhi, India
Meera Mahalingam, M.D, PhD, FRCPath
HONORS
2003-2007
Director of Quality Assurance, American Society of Dermatopathology, USA
2003-2007
Director of Laboratory Proficiency, American Society of Dermatopathology, USA
1993
Fellow of the Royal College of Pathologists (FRCPath), London, UK
LICENSES AND CERTIFICATION
1995-
Commonwealth of Massachusetts (#154499)
2000-2009
State of Connecticut (#039439)
1989-
General Medical Council, UK
1993-
Pathology, Royal College of Pathologists, UK
1999-
Anatomic & Clinical Pathology, American Board of Pathology, USA
2000-
Dermatopathology, American Boards of Dermatology and Pathology, USA
DEPARTMENTAL AND UNIVERSITY COMMITTEES
2010-
Dermatology Executive Committee
2008-
Medical School Admissions Committee (MD and MD/PhD programs)
Boston University School of Medicine, Boston, MA
2008-
Dermatology Residency Selection Committee, Department of Dermatology
Boston University School of Medicine, Boston, MA
2005-2007
Dermatology Residency Selection Committee, Department of Dermatology
UMASS Medical School, Worcester, MA, USA
NATIONAL
COMMITTEES
2010-
Ad Hoc Reviewer, NCI SPORE applications in skin Cancer, NIH
MAJOR ADMINISTRATIVE RESPONSIBILITIES
2010-
Director, Dermatopathology Fellowship Program, BUSM, Boston, USA
2007- 2010
Associate Director, Dermatopathology Fellowship Program, BUSM, Boston, USA
2005-2007
Dermatopathology Fellowship Program Director, UMASS Medical School, Worcester, USA
2005-2007
Director, Dermatopathology, UMASS Memorial Health Care, Worcester, MA
PROFESSIONAL OFFICES HELD
2009-
ACCME Task Force representative, American Society of Dermatopathology, USA
2003-2007
Director, Quality Assurance, American Society of Dermatopathology, USA
2003-2007
Director, Laboratory Proficiency, American Society of Dermatopathology, USA
2003–
Board Member, American Society of Dermatopathology
EDITORIAL BOARDS
2008-
CME Section Editor, Journal of Cutaneous Pathology
2007-
Editorial Board, Journal of Cutaneous Pathology
2
Meera Mahalingam, M.D, PhD, FRCPath
MEMBERSHIPS
2010-
Society for Melanoma Research
2007-
Society of Investigative Dermatology
2005-
International Society of Dermatopathology
2000-
Massachusetts Medical Society
1998-
American Society of Dermatopathology
1998-
New England Dermatological Society
INVITED REVIEWER
2010-
Key Opinions
2010-
Modern Pathology
2010-
Archives of Dermatological Research
2009-
Differentiation
2009-
European Journal of Dermatology
2009-
Human Pathology
2009-
Clinical and Experimental Dermatology
2008-
American Journal of Dermatopathology
2008-
Expert Review of Dermatology
2006-
Head and Neck Medicine
2005-2007
Journal of the American Academy of Dermatology
2004-
Journal of Cutaneous Pathology
2000-2004
Indian Journal of Dermatology, Venereology and Leprosy
1993-1995
Journal of AIDS and Human Retroviruses
CME COURSES CONDUCTED
2008-
CME Section of the Journal of Cutaneous Pathology, USA
(24 AMA PRA Category 1 Credits™ offered / year)
2002-2007
Quality Assurance program for the American Society of Dermatopathology, USA
(4 AMA PRA Category 1 Credits™ offered/year)
2002-2007
Laboratory Proficiency program for the American Society of Dermatopathology, USA
(4 AMA PRA Category 1 Credits™ offered/year)
RESEARCH GRANTS
ONGOING SUPPORT
2008-2010
Center for Clinical and Translational science Pilot Projects grant
Co-investigator (PI: Michael Greene, MD, PhD, UMASS Medical School)
Grant title: Role of IGFBP7 and IGFBP7 Pathway Components in the Development and
Treatment of Cancers Involving Oncogenic BRAF. Budget: $75,000/year
PAST SUPPORT
2009
UROP Faculty Matching Grant, BU
PI; Grant, Grant title: Genomic analyses of proliferative nodules in congenital nevi.
Budget: $1,500
1994-1994
South East Thames Regional health Authority, London, UK
PI; Grant title: HIV Infection in African women. Budget: 52,000$/year
3
Meera Mahalingam, M.D, PhD, FRCPath
PENDING GRANTS
2010-
Yale Melanoma SPORE Grant
Co-PI with Narendra Wajapeyee, PhD (Yale Medical School)
Grant title: Mechanisms for Genetic regulation of Immune evasion in malignant
melanoma Budget: $60,000/year
TEACHING EXPERIENCE AND RESPONSIBILITIES
POSTGRADUATE TEACHING
2007-
Bi-monthly “Hands-on” slide session, Dermatology and Pathology residents
Boston Medical Center, Boston, MA, USA
2007-
Daily “Hands-on” slide session, Dermatopathology fellows (when on service)
Boston Medical Center, Boston, MA, USA
2005-2007
Weekly Hands-on” slide session, Dermatology and Pathology residents
2005-2007
Daily “Hands-on” slide session, Dermatopathology fellows (when on service)
UMASS Memorial Health Care, Worcester, MA, USA
UMASS Memorial Health Care, Worcester, MA, USA
GRADUATE TEACHING
2010
Medical student mentored, Elizabeth Park, BUSM, Boston, MA, USA
2008-2009
First Reader, K DeCarlo, Masters in Medical Sciences, BUSM, Boston, MA
2008-2009
Second Reader, S Thi, Masters in Medical Sciences, BUSM, Boston, MA, USA
2008-2009
Medical student mentored, Lisa Nguyen, BUSM, Boston, MA, USA
2007-2008
First Reader, A Emley, Masters in Medical Sciences, BUSM, Boston, MA, USA
2005-2007
Medical students mentored, Nicole Leboeuf and Gary Mendese, UMASS Medical School,
Worcester, MA, USA
UNDERGRADUATE TEACHING
2010-
Disease and Therapy Course, Lecturer, BUSM, Boston, MA
2005-2007
Dermatology Block Co-Director, Biology of Disease Course, UMASS Medical School,
Worcester, USA
1992-1995
Course Director, Immunology for Medical students, Kings College School of Medicine,
London, UK
INVITED LECTURES AND PRESENTATIONS
1.
Twins - Identical or fraternal?, Consultation Session, American Society of Dermatopathology Annual Meeting,
Atlanta, October 9th, 2010
2.
Hair follicle stem cells- past present and the future. Indian Trichology Society, Chennai, June, 2010
3.
Look alikes in neoplastic Dermatopathology, Consultation Session, American Society of Dermatopathology Annual
Meeting, Chicago, September 29th, 2009
4.
“Fun”ky lymphocytic infiltrates. DERMACON 2009, 37th National conference of Indian Association of
Dermatologists Venereologists and Leprologists, Bangalore, India, January 9th, 2009
5.
“Sarcoidal” granulomas - demystified. DERMACON 2009, 37th National conference of Indian Association of
Dermatologists, Venereologists and Leprologists, Bangalore, India, January 8th, 2009
4
Meera Mahalingam, M.D, PhD, FRCPath
6.
Panelist, New England Dermatologic Society, December meeting, Boston, MA, USA, December 6th, 2008
7.
Panelist, Self Assessment Session, American Society of Dermatopathology Annual Meeting, Chicago, October 19th,
2006
8.
“Say what you see”. DERMACON 2006, 34th National conference of Indian Association of Dermatologists,
Venereologists and Leprologists, Hyderabad, India, February 2nd, 2006
9.
Immune reconstitution Syndrome in HIV infection – does it exist? DERMACON 2006, 34th National conference of
Indian Association of Dermatologists, Venereologistsand Leprologists, Hyderabad, India, February 1st, 2006
10. HIV, HAART and the skin. Indian Council for Medical Research, Chennai, India, January 26th, 2006
11. Molecular Diagnostics in Dermatopathology – Useful or useless? XIth International CME on Surgical Pathology,
Kolkota, India, January 25th, 2006
12. Clinicopathologic slide session. St Johns Medical College, Bangalore, India, March 1st, 2005
13. Clinicopathologic slide session. St Johns Medical College, Bangalore, India, February 3rd, 2004
14. Cutaneous lymphomas. St Johns Medical College, Bangalore, India, February 2nd, 2004
15. Atypical cutaneous lymphoid cell infiltrates. Apollo Hospital, Chennai, India, February 1st, 2004
16. Atypical pilar leiomyoma – The cutaneous counterpart of uterine symplastic leiomyoma. American Society of
Dermatopathology Annual Meeting, Baltimore, Maryland, October 18th, 2000
17. Primary amyloidoses of the auricular concha – A case report and review. American Society of Dermatopathology
Annual Meeting, Baltimore, Maryland, October 18th, 2000
18. Lymphocyte counts and time: Trends in HIV+ individuals. VIII International Conference on AIDS, Amsterdam. July
5th, 1992
19. T cell Activation in HIV Infection. British Society of Immunology, London. October 16th, 1991
20. Immune Activation in HIV infection. Guys' Hospital, London, April 3rd, 1991
21. The Role of Platelets in Metastasis. Jackson Laboratories of Genetics, Maine, March 14th, 1988
22. Role of platelets in experimental metastasis with cloned murine fibrosarcoma cell lines. Federation of American
Society for Experimental Biology (FASEB) Washington. March 12th, 1987
ORIGINAL PEER REVIEWED ARTICLES
1.
Abbas O, Richards JE, Mahalingam M. Fibroblast-activation protein- single marker that confidently differentiates
morpheaform/infiltrative basal cell carcinoma from desmoplastic trichoepithelioma. (submitted, 2010)
5
Meera Mahalingam, M.D, PhD, FRCPath
2.
Abbas O, Richards JE, Yaar R, Mahalingam M. Stem cell markers (cytokeratin 15, cytokeratin 19 and p63) in in situ
and invasive cutaneous epithelial lesions (submitted, 2010)
3.
Brahmbhatt M, Yang S, Mahalingam M. Proliferative nodules in congenital nevi - A histopathologic, genomic and
immunohistochemical reappraisal (submitted, 2010)
4.
Emley A, Nguyen LP, Yang S, Mahalingam M. Somatic mutations in GNAQ in amelanotic/hypomelanotic blue nevi
(in press, Hum Pathol, 2010)
5.
Hoang MP, Srivastava A, Mahalingam M. Expression of Stem Cell Markers (Cytokeratin 15 and Nestin) in Primary
Eccrine and Apocrine Neoplasms. (in press, Am J Dermatopathol, 2010)
6.
Pongpudpunth M, Bhawan J, Al-Natour SH, Mahalingam M. Nestin positive stem cells in neurofibromas from
patients with neurofibromatosis type 1 (NF1) – tumorigenic or incidental? (in press, Am J Dermatopathol, 2010)
7.
Ronaghy A, Yaar R, Goldberg LJ, Mahalingam M, Bhawan J. Perineural involvement: what does it mean? (in press,
Am J Dermatopathol, 2010)
8.
Mahalingam M, Hoang MP. D2-40 expression in primary scarring and non-scarring alopecia. Am J Dermatopathol,
2010, Apr 20 [Epub ahead of print]
9.
Wajapayee N, Serra R, X Zhu, Mahalingam M, Green MR. Role for IGFBP7 in senescence induction by BRAF
oncogene. Cell, 2010:141:1
10. Mahalingam M, Nguyen LP, Richards JE, Muzikansky A, Hoang MP. The Diagnostic Utility of Immunohistochemistry
in Distinguishing Primary Skin Adnexal Carcinomas from Metastatic Adenocarcinoma to Skin: an
Immunohistochemical Reappraisal Using Cytokeratin 15, Nestin, p63, D2-40, and Calretinin. Mod Pathol, 2010;
23(5): 713
11. DeCarlo K, Yang S, Emley A, Wajapeyee N, Green M, Mahalingam M. Oncogenic BRAF positive dysplastic nevi and
the tumor suppressor IGFBP7– challenging the concept of dysplastic nevi as precursor lesions? Hum Pathol, 2010;
41(6):886
12. Wajapeyee N, Kapoor V, Mahalingam M, Green M. Efficacy of IGFBP7 for Treatment of Metastatic Melanoma and
other Cancers in Mouse Models and Human Cell Lines. Molecular Cancer Therapeutics 2009; 8(11):3009
13. Nguyen LP, Emley A, Wajapeyee N, Green MR, Mahalingam M. BRAFV600E and the tumor suppressor IGFBP7 in
atypical genital nevi. Br J Dermatol 2010;162(3):677
14. Emley A, Yang S, Wajapeyee N, Green MR, Mahalingam M. Oncogenic BRAF and the tumor suppressor IGFBP7 in
the genesis of atypical spitzoid nevomelanocytic proliferations. J Cut Pathol 2010; 37(3):344
15. Abbas O, Mahalingam M. Tumor of the follicular infundibulum – an epidermal reaction pattern? Am J
Dermatopathol 2009; 31:626
16. Pongpudpunth M, Farber J, Mahalingam M. Follicular porokeratosis: Distinct entity or histologic variant?
J Cut Pathol 2009; 36:1195
6
Meera Mahalingam, M.D, PhD, FRCPath
17. Pongpudpunth M, Keady M, Mahalingam M. Morphometric analyses of elastic tissue fibers in dermatofibroma:
clues to etiopathogenesis. J Cut Pathol 2009; 36: 1083
18. Pozdnyakova O, Hoang MP, Dresser K, Mahalingam M. Prognostic value of E-cadherin, -catenin, CD44 and
Her2neu in metastatic adenocarcinoma. Arch Pathol Lab Med 2009; 133:1285
19. Hoang MP, Keady M, Mahalingam M. Stem cell markers (cytokeratin 15, CD34 and nestin) in primary scarring and
non-scarring alopecia. Br J Dermatol 2009; 160:609
20. Dadzie O, Yang S, Emley A, Keady M, Bhawan J, Mahalingam M. RAS and RAF mutations in banal melanocytic
aggregates contiguous with primary cutaneous melanoma – clues to melanomagenesis. Br J Dermatol 2009;
160:368
21. Hoang MP, Mahalingam M, Bhawan J, Kapur P, High WA. Acute Generalized Exanthematous Pustulosis: a Clinical
and Histologic Study of Forty-Five Cases. Malaysian J Dermatol 2008; 21:23
22. Pozdnyakova O, Mahalingam M. Involvement of the bulge region in primary scarring alopecia. J Cutan Pathol
2008; 35:922
23. Wajapayee N, Serra R, Zhu X, Mahalingam M, Green MR. Oncogenic BRAF induces sensescence through an
autocrine/paracrine pathway mediated by the secreted protein IGFBP7. Cell 2008; 132:363
24. Chhibber V, Dresser K, Mahalingam M. MSH-6 - extending the reliability of immunohistochemistry as a screening
tool in patients with Muir-Torre syndrome. Mod Pathol 2008; 21:159
25. Hoang MP, Dresser K, Kapur P, High WA, Mahalingam M. Microcystic adnexal carcinoma: An immunohistochemical
appraisal. Mod Pathol 2008; 21:178
26. Lisovsky M, Hoang MP, Dresser K, Kapur P, Bhawan J, Mahalingam M. Apo D in CD34-positive and CD34-negative
cutaneous neoplasms: a useful marker in differentiating superficial acral fibromyxoma from dermatofibrosarcoma
protuberans. Mod Pathol 2008; 21:31
27. Dadzie O, Mahalingam M, Helou El, Phillips T, Bhawan J. Adverse cutaneous reactions to soft tissue fillers - A
review of the histological features. J Cutan Pathol 2008; 35:536
28. LeBoeuf NR, Mahalingam M. Acanthomatous superficial sebaceous hamartoma. A study of six cases with
clarification of the nomenclature. J Cutan Pathol 2007; 34:865
29. Mahalingam M. Follicular acantholysis – a subtle clue to the early diagnosis of pemphigus vulgaris.
Am J Dermatopathol 2005; 27:237
30. Mahalingam M, Goldberg LJ. Atypical pilar leiomyoma – Cutaneous counterpart of uterine symplastic leiomyoma?
Am J Dermatopathol 2001; 23:299
31. Underhill JA, Mahalingam M, Peakman M, Wessely S. Lack of association between HLA genotype and chronic
fatigue syndrome. Eur J Immunogenet 2001; 28:425
7
Meera Mahalingam, M.D, PhD, FRCPath
32. Mahalingam M, LoPiccolo D, Byers HR. Expression of PGP 9.5 in granular cell nerve sheath tumors: An
immunohistochemical study of six cases. J Cutan Pathol 2001; 28:282
33. Peakman M, Deale A, Field R, Mahalingam M, Wessely S. Clinical improvement in CFS is not associated with
lymphocyte subsets of function or activation. Clin Immunol Immunopathol 1997; 82:83
34. Mahalingam M, Peakman M, McManus T, Pozniak AP, Davies ET, Vergani D. Abnormalities of CD45 isoform
expression in HIV infection. Clin Immunol Immunopathol 1996; 81:210
35. Lowe N, Paine K, Clark R, Mahalingam M, Pozniak A. AIDS survival and progression in black Africans living in
South London, 1986-94. Genitourin Med 1996; 72:12
36. Senaldi G, Davies ET, Mahalingam M, Lu J, Pozniak AP, Peakman M, Reib KB, Vergani D. Circulating levels of
mannose binding protein in HIV infection. J Infect 1995; 31:145
37. Mahalingam M, Pozniak AP, McManus TJ, Vergani D, Peakman M. Cell cycling in HIV infection: in vivo analysis of
activated lymphocytes. Clin Exp Immunol 1995; 102:481
38. Peakman M, Mahalingam M, Pozniak AP, McManus TJ, Phillips AN, Vergani D. Markers of immune cell activation
and disease progression in HIV disease. Adv Exp Med Biol 1995; 374:17
39. Mahalingam M, Peakman M, Pozniak AP, McManus T, Vergani D. Naive and memory T cell subsets in HIV-induced
disease. Immunology 1994; 83:60
40. Mahalingam M, Peakman M, McManus T, Pozniak AP, Davies ET, Vergani D. T cell activation and disease severity in
HIV infection. Clin Exp Immunol 1993; 93:337
41. Ugen KE, Mahalingam M, Kao KJ, Klein PA. Inhibition of Tumor Cell-Induced Platelet Aggregation and Experimental
Tumor Metastasis by the Synthetic Gly-Arg-Gly-Asp-Ser Peptide. J Natl Cancer Inst 1988; 80:18
42. Mahalingam M, Ugen KE, Kao KJ, Klein PA. Functional Role of Platelets in Experimental Metastasis Studied with
Cloned Murine Fibrosarcoma Cell Variants. Cancer Res 1988; 88:1460
43. Mahalingam M, Ugen KE, Kao KJ, Klein PA. Role of platelets in experimental metastasis with cloned murine
fibrosarcoma cell lines. FASEB J 1987; 46:5835
CASE REPORTS
1.
Nguyen LP, Mahalingam M, Garg A. Clinical Case Modules: Dermatology Clinical Case Modules: 40-year-old
woman with a dark mole. (submitted)
8
Meera Mahalingam, M.D, PhD, FRCPath
2.
Elpern D, Mahalingam M. Evolving CTCL in a 23-year old male. March 2010; www.vgrd.org
3.
Alberta-Wszolek L, Mousette AM, Mahalingam M, Levin NA. Linear IgA bullous dermatosis following influenza
vaccination. Dermatology Online Journal 2010; 15(11):3
4.
Nguyen LP, Mahalingam M, Garg A. Clinical Case Modules: Dermatology Clinical Case Modules: 70-year-old man
with a red, crusty bump on his right arm. MedEdPORTAL;2010
http://services.aamc.org/30/mededportal/servlet/s/segment/mededportal/?subid=8055
5.
Abbas O, Reddy K, Demierre MF, Blanchard RA, Mahalingam M. Epidermotropic metastatic mucoepidermoid
carcinoma (in press, Am J Dermatopathol, 2010, May 20 [Epub ahead of print])
6.
Nguyen LP, Mahalingam M, Garg A. Clinical Case Modules: Dermatology Clinical Case Modules: 62-year-old man
with a facial growth. MedEdPORTAL;2010
7.
Mahoney A, Garg A, Wolpowitz D, Mahalingam M. Atypical granular cell tumor - apropos of a case with
indeterminate malignant potential. Am J Dermatopathol, 2010;32:370
8.
Yu Y, Demierre MF, Mahalingam M. Anaplastic kaposi’s sarcoma: an uncommon histologic phenotype with an
aggressive clinical course. (J Cut Pathol 2009; DOI: 10.1111/j.1600-0560.2009.01389.x)
9.
Yaar R, Rothman K, Mahalingam M. When dead cells tell tales - cutaneous involvement by precursor T-cell acute
lymphoblastic lymphoma with an uncommon phenotype. Am J Dermatopathol 2010; 32:183
10. Pozdnyakova O, Garg A, Mahalingam M. Nodular vasculitis - a novel cutaneous manifestation of autoimmune
colitis. J Cutan Pathol 2008; 35:315
11. Bordeaux J, O’Brien M, Mahalingam M, Wiss K. Disseminated fusariosis with multiple target lesions in a patient
with leukemia. Int J Dermatol 2008; 47:13
12. Chhibber V, Lyle S, Mahalingam M. Ductal Eccrine Carcinoma with Squamous Differentiation – apropos a case. J
Cutan Pathol 2007; 34:503
13. Pattee SF, Bordeaux J, Mahalingam M, YB Nitzan, ME Maloney. Verrucous carcinoma of the scalp. J Am Acad
Dermatol 2007; 56:506
14. Garg A, Alavian, C, Mahalingam M. Pruritic patches on the back and papules on the legs. Arch Dermatol 2007;
143:255
15. Mendese G, Mahalingam M. Histopathology of Gottron’s Papules – Utility in Diagnosing Dermatomyositis. J Cutan
Pathol 2007; 34:793
16. Coburn V, Radfar A, Snook D, Mahalingam M. Cutaneous Oncocytoma – a report of three cases and review of the
literature. J Cutan Pathol 2007; 34:355
17. Mahalingam M, Kveaton JF, Bhawan J. Cutaneous neuroendocrine adenoma - an uncommon neoplasm. J Cutan
Pathol 2006; 33:315
9
Meera Mahalingam, M.D, PhD, FRCPath
18. Mahalingam M, Alter JN, Bhawan J. Multiple cellular neurothekeomas – A case report and review on the role of
immunohistochemistry as a histologic adjunct. J Cutan Pathol 2006; 33:51
19. Mahalingam M, Bhawan J. Cutaneous anaplastic large cell lymphoma – a case report. Indian J Dermatol Venereol
Leprol 2004; 70:170
20. Mahalingam M, Bhawan J. Metastatic papillary carcinoma of the thyroid. J Cutan Pathol 2004; 31:509
21. Meyers SW, Bercovitch L, Polley K, Taira J, DeCamp M, Mahalingam M, Grillone G, Grande D. Massive exophytic
abscesses and fibrotic masses of the chin: a variant of the follicular occlusion triad. J Am Acad Dermatol 2003;
48:S47
22. Stefanato CM, Mahalingam M, Kates SG, Bhawan J. Skeletal muscle regeneration – report of a case simulating
squamous cell carcinoma. Gital Dermatol Venerol 2003; 138:41
23. Mahalingam M, Kim E, Bhawan J. Morphea-like tattoo reaction. Am J Dermatopathol 2002; 24:392
24. Mahalingam M, Bhawan J, Finn R, Stefanato CM. Tumor of the follicular infundibulum with sebaceous
differentiation. J Cutan Pathol 2001; 28:314
25. Mahalingam M, Byers HR. Intra-epidermal and intradermal sebocrine adenoma with cystic degeneration and
hemorrhage. J Cutan Pathol 2000; 27:472
26. Mahalingam M, Ottlinger ME. False negative qualitative cardiac troponin-T in a 79-year old man with myocardial
infarction. JAMA 1997; 278:2143
27. Mahalingam M, Ottlinger ME. A case against the specificity of “cardiac” troponin-T. J Clin Pathol 1996; 49:766
INVITED REVIEWS/BOOK CHAPTERS
1.
Abbas O, Mahalingam M. Desmoplasia – Not always a bad thing (in press, Histopathology, 2010)
2.
DeCarlo K, Emley A, Dadzie O, Mahalingam M. Laser capture microdissection: methods and applications. Methods
in Molecular Biology series, Humana Press, 2010
3.
Dadzie O, Neat M, Emley A, Keady M, Bhawan J, Mahalingam M. Molecular diagnostics- An emerging frontier in
dermatopathology (in press, Am J Dermatopathol, 2010)
4.
Mahalingam M, Bhawan J, Eisen D, Hu L. Lyme Borreliosis. In Freedberg IM et al, eds. Fitzpatrick’s Dermatology in
General Medicine, 8th ed., New York, McGraw-Hill, 2010
5.
Hoang MP, Mahalingam M, Selim MA. A Review of Immunohistochemistry in the Diagnosis of Cutaneous
Neoplasms. Future Oncology 2010; 6:93
6.
Abbas O, Mahalingam M. Epidermal stem cells: Practical perspectives and potential uses. Br J Dermatol 2009;
161:228
10
Meera Mahalingam, M.D, PhD, FRCPath
7.
Abbas O, Mahalingam M. Cutaneous Sebaceous neoplasms as markers of Muir-Torre syndrome- A diagnostic
algorithm. J Cut Pathol 2009; 36:613
8.
Mahalingam M, Bhawan J. Cutaneous spirochetal disease – a review. Malaysian J Dermatol 2007; 19:19
9.
Mahalingam M, Bhawan J, Chomat A-M, Hu L. Lyme Borreliosis. In Freedberg IM et al, eds. Fitzpatrick’s
Dermatology in General Medicine, 7th ed., New York, McGraw-Hill, 2007
10. Mahalingam M, Seder RH, Allam CA. Cryoglobulins: Transfusion Perspectives. Transfus Med 1996; 39:91
INVITED EDITORIALS
1.
Mahalingam M. On oncogenic BRAF, melanomagenesis and organ transplant recipients – “the more we know, the
less we understand”. Eur J Dermatol, 2010; 20:143
2.
Mahalingam M. Quality assurance and continuing medical education in dermatopathology – the ASDP way. J Cutan
Pathol 2008; 35:516
LETTERS
1.
Mahalingam M. When a negative is a positive! J Cutan Pathol. 2009:36:1022
2.
Fong G, Capaldi L, Sweeney S, Wiss K, Mahalingam M. Congenital Darier disease. JAAD 2008:59 (2 Suppl 1):S50
3.
Pozdnyakova O, Mahalingam M. CD99 - much ado about nothing? J Cutan Pathol 2008; 35:86
4.
Mahalingam M. Atypical cutaneous lymphocytic infiltrates – paucicellularity and “pseudo”clonality. J Cutan Pathol
2003; 30:521
5.
Mahalingam M, Palko M, Steinberg-Benjes L, Goldberg LJ. Amyloidosis of the auricular concha – An uncommon
variant of localized cutaneous amyloidosis. Am J Dermatopathol 2002; 24:447
6.
Dhingra J, Mahalingam M. Antibodies to 68 kd antigen- specific for inner ear disease? Laryngoscope 1997; 107:
101
7.
Mahalingam M. Analysis of surface density of expression of molecules by flow cytometry. Cytometry 1996; 24:
190
8.
Mahalingam M. CD29 - true marker of “memory”? J Acquir Immune Defic Syndr 1996; 11:411
9.
Mahalingam M, Dhingra J. Rights of overseas doctors to practice in the UK. Lancet 1996; 347:62
10. Mahalingam M. Epstein-Barr virus and autoimmune hepatitis. Lancet 1995; 346:913
11. Peakman M, Mahalingam M, Leslie RDG, Vergani D. Co-expression of CD45RA (naive) and CD45R0 (memory) T cell
markers. Lancet 1994; 343:424
11
Meera Mahalingam, M.D, PhD, FRCPath
BOOK REVIEWS
1.
Farvolden D, Mahalingam M. The structure of the human hair follicle. (by David A Whiting) JAAD 2007; 56:717
2.
Biswas A, Mahalingam M. Dysplasia and Atypia - Impediments Inordinate to Understanding in Pathology (by
François Milette, Mark Hurt and A Bernard Ackerman) Dermatopathol: Practical and Conceptual January - March
2010; Volume 16, #1
ABSTRACTS
1.
Biswas A, Richards JE, Massaro J, Mahalingam M. Mast cells in non- mast cell dyscrasias: innocent bystander or
maëstro conductor? (submitted, American Society Of Dermatopathology Annual Meeting, Atlanta, 2010)
2.
Brahmbhatt M, Yang S, Mahalingam M. Proliferative nodules in congenital nevi - A histopathologic, genomic and
immunohistochemical reappraisal (submitted, American Society Of Dermatopathology Annual Meeting, Atlanta,
2010)
3.
Emley A, Nguyen LP, Yang S, Mahalingam M. Frequency of somatic mutations in GNAQ in primary, pigmented
dermal melanocytic proliferations. Society of Investigative Dermatology Annual Meeting, Atlanta, 2010
4.
Anurukpaiboon P‡, Tierney E, Mahalingam M. Retiform hemangioendothelioma in a 7-year-old boy for 4 years
American Academy Of Dermatology Annual Meeting, Miami, 2010; ‡Platform presentation
5.
DeCarlo K‡, Yang S, Emley A, Wajapeyee N, Mahalingam M. Oncogenic BRAF and the tumor Suppressor IGFBP7 in
dysplastic nevi. American Society Of Dermatopathology Annual Meeting, Chicago, 2009; ‡Platform presentation
6.
Pongpudpunth M, Bhawan J, Al-Natour SH, Mahalingam M. Nestin positive stem cells in neurofibromas in
neurofibromatosis 1. American Society Of Dermatopathology Annual Meeting, Chicago, 2009
7.
Nguyen LP, Garg A, Mahalingam M. Interactive case-based teaching modules for the medical student curriculum
in Dermatology: A module on basal cell carcinoma. Fourth Annual John McCahan Medical education Day, Boston,
2009
8.
Nguyen LP, Emley A, Wajapeyee N, Mahalingam M. Frequency of BRAFV600E mutation in atypical genital nevi.
Society of Investigative Dermatology Annual Meeting, Montreal, 2009
9.
Yaar R, Rothman K, Mahalingam M. When dead cells tell tales - cutaneous involvement by precursor T-cell acute
lymphoblastic lymphoma with an uncomon phenotype. American Society Of Dermatopathology Annual Meeting,
San Francisco, 2008
10. Pongpudpunth M, Keady M, Mahalingam M. Morphometric analyses of density of elastic tissue fibers in
dermatofibroma: clues to etiopathogenesis. American Society Of Dermatopathology Annual Meeting, San
Francisco, 2008
11. Pongpudpunth M, Farber J, Mahalingam M. Follicular Porokeratosis: Distinct clinical entity or histologic variant?
American Society Of Dermatopathology Annual Meeting, San Francisco, 2008
12. Dadzie O‡, Yang S, Emley A, Keady M, Bhawan J, Mahalingam M. Nevic aggregates in cutaneous melanomas precursor or incidental lesion? American Society Of Dermatopathology Annual Meeting, San Francisco, 2008
12
Meera Mahalingam, M.D, PhD, FRCPath
‡Platform
presentation
13. Mahalingam M, Yang S, Emley A, Wajapeyee N, Green MR. Loss of novel Tumor Suppressors may Play a Role in the
genesis of atypical spitzoid nevomelanocytic proliferations not exhibiting the BRAF Mutation. International
Investigative Dermatology Annual meeting, 2008
14. Hoang MP, Mahalingam M, Bhawan J, Kapur P, High WA. Acute Generalized Exanthematous Pustulosis: a Clinical
and Histologic Study of Forty-Five Cases. United States and Canadian Academy of Pathology Annual meeting,
Denver, 2008
15. Wajapayee N, Serra R, Zhu X, Mahalingam M, Green MR‡. Dissecting the basis of oncogene-induced senescence in
apoptosis through a genome-wide RNA interference screen. Protein Killing tumor cells meeting, Leiden,
Netherlands, 2007; ‡Platform presentation
16. Chhibber V, Mahalingam M. MSH-6 - extending the reliability of immunohistochemistry as a screening tool in
patients with Muir-Torre syndrome. American Society Of Dermatopathology Annual Meeting, Baltimore, 2007
17. Pozdnyakova O, Lyle S, Mahalingam M. Role of the bulge region in scarring alopecia. United States and Canadian
Academy of Pathology Annual meeting, San Diego, 2007
18. Lisovsky M, Dresser K, Mahalingam M. The utility of Apo D as a diagnostic Immunohistochemical adjunct in
dermatofibrosarcoma protuberans. United States and Canadian Academy of Pathology Annual meeting, San Diego,
2007
19. Pozdnyakova O, Garg A, Mahalingam M. Erythema induratum - a novel cutaneous manifestation of autoimmune
colitis. American Society Of Dermatopathology Annual Meeting, Chicago, 2006
20. Pozdnyakova O, Mahalingam M. Cutaneous metastasis of adenocarcinoma of the esophagus American Society Of
Dermatopathology Annual Meeting, Chicago, 2006
21. Sinopoli M‡, Papa D, Levin N, Mahalingam M. Pemphigus vegetans – A gynecologic disorder? Massachusetts
Medical Society Annual Meeting, Waltham, Massachusetts, April, 2006; ‡Platform presentation
22. Mahalingam M. Oncocytoma of the eyelid – An uncommon benign tumor. American Society Of Dermatopathology
Annual Meeting, Phoenix, Arizona, October, 2002
23. Mahalingam M. “Hybrid” nerve sheath tumor with features of neurofibroma and schwannoma. American Society Of
Dermatopathology Annual Meeting, Phoenix, Arizona, October, 2002
24. Stefanato CM, Mahalingam M, Kates SG, Bhawan J. Skeletal muscle regeneration mimicking poorly differentiated
squamous cell carcinoma: A potential diagnostic pitfall. American Society Of Dermatopathology Annual Meeting,
Baltimore, Maryland, October, 2000
25. Mahalingam M‡, Goldberg LJ. Atypical pilar leiomyoma – The cutaneous counterpart of uterine symplastic
leiomyoma. American Society Of Dermatopathology Annual Meeting, Baltimore, Maryland, October, 2000
‡Platform
presentation
13
Meera Mahalingam, M.D, PhD, FRCPath
26. Mahalingam M‡, Steinberg-Benjes L, Goldberg LJ. Primary amyloidoses of the auricular concha – A case report and
review. American Society Of Dermatopathology Annual Meeting, Baltimore, Maryland, October, 2000
‡Platform
presentation
27. Mahalingam M, Byers RH. Intradermal hemorrhagic sebocrine adenoma with cystic degeneration – A new variant.
American Society Of Dermatopathology Annual Meeting, La Jolla, CA, November, 1999
28. Mahalingam M, Byers RH. Myxoid neurothekeoma presenting as focal mucinosis. American Society Of
Dermatopathology Annual Meeting, La Jolla, CA, November, 1999
29. Mahalingam M, Wyandt HE, O’Hara CJ. FISH in early myelodysplastic syndrome. American Society of Clinical
Pathology National Meeting, Washington DC, October, 1998
30. Mahalingam M, O’Hara CJ, Wyandt HE. FISH in stained bone marrow aspirate smears-A rapid method to evaluate
cell lineages. American Society of Clinical Pathology National Meeting, Philadelphia, September, 1997
31. Mahalingam M, Mesa G, Arkin CA, Shapiro DS. Sodium Polyanethol Sulfonate: An inhibitor of Coagulase. 97
th
American Society of Microbiology General Meeting, Miami, May, 1997
32. Mahalingam M‡, Pozniak AP, McManus TJ, Vergani D, Peakman M. Cell cycling in HIV infection: in vivo analysis of
activated lymphocytes. American Society of Clinical Pathology Boston, April, 1996
‡Platform
presentation
33. Lowe N‡, Paine K, Clark R, Mahalingam M, Pozniak A. Survival with HIV infection of HIV-infected Africans who live
in London. IXth International Conference on AIDS and STD in Africa, Kampala, December, 1995
‡Platform
presentation
34. Phillips AN‡, Mahalingam M, Peakman M, Pozniak A, McManus TJ, Vergani D. Viral and immunologic monitoring of
HIV: an adjusted CD4 count. 2nd National Conference on Human Retroviruses, Washington, DC, January, 1995
‡Platform
presentation
35. Peakman M‡, Mahalingam M, Pozniak A, McManus TJ, Phillips AN, Vergani D. Markers of immune cell activation
and disease progression. International Conf on Cellular Approaches to the control of HIV disease , Paris, July, 1994
‡Platform
presentation
36. Mahalingam M‡, Peakman M, Pozniak A, McManus TJ, Vergani D. Memory and Naive T Cells in HIV Disease:
Markers for Disease Progression? IXth International AIDS Conference, Berlin, June, 1993; ‡Platform presentation
37. Mahalingam M‡, Peakman M, McManus TJ, Vergani D. CD4 and CD8 Counts alterations with time in HIV+
individuals. British Society of Immunology Autumn Meeting, London, November, 1992
‡Platform
presentation
38. Todd P, Mahalingam M, Higgins E, Mufti G, Vergani D, du Vivier AWP. Preferential Expression of CD25 (IL-2R) on
Peripheral Blood CD4+ Helper T Lymphocytes in Mycosis Fungoides. British Association of Dermatologists, 72nd
Annual Meeting, Bournemouth, July, 1992
14
Meera Mahalingam, M.D, PhD, FRCPath
39. Mahalingam M‡, Davies ET, McManus TJ, Tee DEH, Peakman M, Vergani D. Differential Expression of T cell
Activation Markers in HIV Infection. VII International Conference on AIDS, Florence, June, 1991
‡Platform
presentation
40. Ugen KE, Mahalingam M, Kao KJ, Klein PA. Effects of a Fibronectin Cell Binding Sequence Peptide in Platelet
Aggregation Induced by cloned Murine Fibrosarcoma Cells. FASEB Washington, March, 1987
15